Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Dermatologic 2Thoracic 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Lymphoma 11Lymphoma, Non-Hodgkin 10Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Hematologic Neoplasms 5Burkitt Lymphoma 5Neuroblastoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Leukemia, Myeloid, Acute 4Breast Neoplasms 4Neoplasm Metastasis 3Myelodysplastic Syndromes 3Melanoma 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Waldenstrom Macroglobulinemia 2Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Myeloproliferative Disorders 2Mycosis Fungoides 2Lymphoma, T-Cell 2

Interventions

Cyclophosphamide 100Rituximab 82fludarabine phosphate 46Peripheral Blood Stem Cell Transplantation 45fludarabine 43Lenalidomide 35Filgrastim 33Methotrexate 32Cytarabine 32Busulfan 32venetoclax 31Etoposide 31Cyclosporine 30Dexamethasone 29Radiotherapy 28Mycophenolic Acid 28Melphalan 28Bendamustine Hydrochloride 25Antilymphocyte Serum 25Vincristine 24Gemcitabine 24ibrutinib 22Whole-Body Irradiation 22Doxorubicin 20Tacrolimus 19Methylprednisolone 18Bortezomib 18Brentuximab Vedotin 16pembrolizumab 15Prednisone 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Ipilimumab × Lymphoid × Clear all
NCT05631886 2023-08-28

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Chinese PLA General Hospital

Phase 1 Recruiting
10 enrolled
Lymphoid

Lymphoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡